The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Treatment and biology of pediatric acute lymphoblastic leukemia
Abstract
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. In the past ALL was intractable but now the survival probability is as high as 80–90%. Improved supportive care, treatment stratification based on relapse risk, biological features of leukemic cells, and optimization of treatment regimens by nationwide and international collaboration have contributed to this dramatic improvement. While including traditional risk factors (e.g. age and leukocyte count at diagnosis), the treatment has been modified based on biological characteristics (aneuploidy and translocation) and treatment response (assessed by minimal residual disease). Treatment for pediatric ALL typically consists of induction therapy with steroids, vincristine, and asparaginase with or without anthracycline, followed by multi‐agent consolidation including high‐dose methotrexate and re‐induction therapy. After consolidation, less intensive maintenance therapy is required for 1–2 years to maintain event‐free survival. Recently, using advanced genomic analysis technology, novel sentinel genomic alterations that may provide more precise stratification or therapeutic targets, were identified. Moreover, in the last decade germline variations have been recognized as similarly important contributors to understanding the etiology and sensitivity of ALL to treatment. A more individualized approach based on genomic features (somatic and germline) and treatment response, the introduction of newly developed agents such as molecular targeted drugs or immunotherapy, and social support including long‐term follow up are required for further improvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
Roberts, K. G., Li, Y., Payne-Turner, D., Harvey, R. C., Yang, Y.-L., Pei, D., McCastlain, K., Ding, L., Lu, C., Song, G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403088 · Cited by 1,377
Topp, M. S., Gökbuget, N., Stein, A. S., Zugmaier, G., O'Brien, S., Bargou, R. C., Dombret, H., Fielding, A. K., Heffner, L., Larson, R. A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71170-2 · Cited by 1,269
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
Pui, C.-H., Yang, J. J., Hunger, S. P., Pieters, R., Schrappe, M., Biondi, A., Vora, A., Baruchel, A., Silverman, L. B., Schmiegelow, K., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1636 · Cited by 1,007
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
van Dongen, J. J., Seriu, T., Panzer-Grümayer, E. R., Biondi, A., Pongers-Willemse, M. J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W. A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04058-6 · Cited by 952
Den Boer, M. L., van Slegtenhorst, M., De Menezes, R. X., Cheok, M. H., Buijs-Gladdines, J. G., Peters, S. T., Van Zutven, L. J., Beverloo, H. B., Van der Spek, P. J., Escherich, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70339-5 · Cited by 930
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Holmfeldt, L., Wei, L., Diaz-Flores, E., Walsh, M., Zhang, J., Ding, L., Payne-Turner, D., Churchman, M., Andersson, A., Chen, S.-C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2532 · Cited by 731
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704
Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia
Mullighan, C. G., Collins-Underwood, J. R., Phillips, L. A. A., Loudin, M. G., Liu, W., Zhang, J., Ma, J., Coustan-Smith, E., Harvey, R. C., Willman, C. L., et al. (2009) · Nature Genetics · doi:10.1038/ng.469 · Cited by 623
Boissel, N., Auclerc, M.-F., Lhéritier, V., Perel, Y., Thomas, X., Leblanc, T., Rousselot, P., Cayuela, J.-M., Gabert, J., Fegueux, N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.053 · Cited by 608
Möricke, A., Zimmermann, M., Reiter, A., Henze, G., Schrauder, A., Gadner, H., Ludwig, W. D., Ritter, J., Harbott, J., Mann, G., et al. (2010) · Leukemia · doi:10.1038/leu.2009.257 · Cited by 520
Russell, L. J., Capasso, M., Vater, I., Akasaka, T., Bernard, O. A., Calasanz, M. J., Chandrasekaran, T., Chapiro, E., Gesk, S., Griffiths, M., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208397 · Cited by 498
Vora, A., Goulden, N., Wade, R., Mitchell, C., Hancock, J., Hough, R., Rowntree, C., & Richards, S. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70600-9 · Cited by 478
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
Moriyama, T., Nishii, R., Perez-Andreu, V., Yang, W., Klussmann, F. A., Zhao, X., Lin, T.-N., Hoshitsuki, K., Nersting, J., Kihira, K., et al. (2016) · Nature Genetics · doi:10.1038/ng.3508 · Cited by 477
Self-citationMoorman, A. V., Ensor, H. M., Richards, S. M., Chilton, L., Schwab, C., Kinsey, S. E., Vora, A., Mitchell, C. D., & Harrison, C. J. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70066-8 · Cited by 390
Rivera, G. K., Pui, C.-H., Abromowitch, M., Mirro, J., Ochs, J. S., Look, A. T., Murphy, S. B., Dahl, G. V., Kalwinsky, D. K., Simone, J. V., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)90733-6 · Cited by 376
Biondi, A., Schrappe, M., De Lorenzo, P., Castor, A., Lucchini, G., Gandemer, V., Pieters, R., Stary, J., Escherich, G., Campbell, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70377-7 · Cited by 330
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995
Gaynon, P., Trigg, M., Heerema, N., Sensel, M., Sather, H., Hammond, G., & Bleyer, W. (2000) · Leukemia · doi:10.1038/sj.leu.2401939 · Cited by 319
Vrooman, L. M., Stevenson, K. E., Supko, J. G., O'Brien, J., Dahlberg, S. E., Asselin, B. L., Athale, U. H., Clavell, L. A., Kelly, K. M., Kutok, J. L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2070 · Cited by 315
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia
Nachman, J. B., Heerema, N. A., Sather, H., Camitta, B., Forestier, E., Harrison, C. J., Dastugue, N., Schrappe, M., Pui, C.-H., Basso, G., et al. (2007) · Blood · doi:10.1182/blood-2006-07-038299 · Cited by 304
Vora, A., Goulden, N., Mitchell, C., Hancock, J., Hough, R., Rowntree, C., Moorman, A. V., & Wade, R. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70243-8 · Cited by 302
Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults
Yasuda, T., Tsuzuki, S., Kawazu, M., Hayakawa, F., Kojima, S., Ueno, T., Imoto, N., Kohsaka, S., Kunita, A., Doi, K., et al. (2016) · Nature Genetics · doi:10.1038/ng.3535 · Cited by 265
Roberts, K. G., Pei, D., Campana, D., Payne-Turner, D., Li, Y., Cheng, C., Sandlund, J. T., Jeha, S., Easton, J., Becksfort, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.4105 · Cited by 256
Buitenkamp, T. D., Izraeli, S., Zimmermann, M., Forestier, E., Heerema, N. A., van den Heuvel-Eibrink, M. M., Pieters, R., Korbijn, C. M., Silverman, L. B., Schmiegelow, K., et al. (2014) · Blood · doi:10.1182/blood-2013-06-509463 · Cited by 248
Self-citationO’Connor, D., Bate, J., Wade, R., Clack, R., Dhir, S., Hough, R., Vora, A., Goulden, N., & Samarasinghe, S. (2014) · Blood · doi:10.1182/blood-2014-03-560847 · Cited by 246
Veerman, A. J., Kamps, W. A., van den Berg, H., van den Berg, E., Bökkerink, J. P., Bruin, M. C., van den Heuvel-Eibrink, M. M., Korbijn, C. M., Korthof, E. T., van der Pal, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70228-1 · Cited by 245
Hirabayashi, S., Ohki, K., Nakabayashi, K., Ichikawa, H., Momozawa, Y., Okamura, K., Yaguchi, A., Terada, K., Saito, Y., Yoshimi, A., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.151035 · Cited by 235
Self-citationHemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management
Morimoto, A., Nakazawa, Y., & Ishii, E. (2016) · Pediatrics International · doi:10.1111/ped.13064 · Cited by 229
Xu, H., Yang, W., Perez-Andreu, V., Devidas, M., Fan, Y., Cheng, C., Pei, D., Scheet, P., Burchard, E. G., Eng, C., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt042 · Cited by 227
Weston, B. W., Hayden, M. A., Roberts, K. G., Bowyer, S., Hsu, J., Fedoriw, G., Rao, K. W., & Mullighan, C. G. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.6770 · Cited by 213
Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia
Moorman, A. V. (2003) · Blood · doi:10.1182/blood-2003-04-1128 · Cited by 213
Harrison, C. J., Moorman, A. V., Schwab, C., Carroll, A. J., Raetz, E. A., Devidas, M., Strehl, S., Nebral, K., Harbott, J., Teigler-Schlegel, A., et al. (2014) · Leukemia · doi:10.1038/leu.2013.317 · Cited by 204
Harris, M., Shuster, J., Carroll, A., Look, A., Borowitz, M., Crist, W., Nitschke, R., Pullen, J., Steuber, C., & Land, V. (1992) · Blood · doi:10.1182/blood.v79.12.3316.3316 · Cited by 201
Kawamata, N., Ogawa, S., Zimmermann, M., Kato, M., Sanada, M., Hemminki, K., Yamatomo, G., Nannya, Y., Koehler, R., Flohr, T., et al. (2008) · Blood · doi:10.1182/blood-2007-05-088310 · Cited by 199
Self-citationHeerema, N. A., Sather, H. N., Sensel, M. G., Zhang, T., Hutchinson, R. J., Nachman, J. B., Lange, B. J., Steinherz, P. G., Bostrom, B. C., Reaman, G. H., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1876 · Cited by 182
Sutcliffe, M. J., Shuster, J. J., Sather, H. N., Camitta, B. M., Pullen, J., Schultz, K. R., Borowitz, M. J., Gaynon, P. S., Carroll, A. J., & Heerema, N. A. (2005) · Leukemia · doi:10.1038/sj.leu.2403673 · Cited by 172
Inherited genetic variation in childhood acute lymphoblastic leukemia
Moriyama, T., Relling, M. V., & Yang, J. J. J. (2015) · Blood · doi:10.1182/blood-2014-12-580001 · Cited by 167
Risk Factors for Traumatic and Bloody Lumbar Puncture in Children With Acute Lymphoblastic Leukemia
Howard, S. C. (2002) · JAMA · doi:10.1001/jama.288.16.2001 · Cited by 166
Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1
Jeha, S., Pei, D., Raimondi, S. C., Onciu, M. M., Campana, D., Chen, C., Sandlund, J. T., Ribeiro, R. C., Rubnitz, J. E., Howard, S. C., et al. (2009) · Leukemia · doi:10.1038/leu.2009.42 · Cited by 154
Bhojwani, D., Pei, D., Sandlund, J. T., Jeha, S., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Shurtleff, S. A., Onciu, M. M., Cheng, C., et al. (2011) · Leukemia · doi:10.1038/leu.2011.227 · Cited by 143
Uckun, F. M., Sensel, M. G., Sather, H. N., Gaynon, P. S., Arthur, D., Lange, B. J., Steinherz, P. G., Kraft, P., Hutchinson, R. J., Nachman, J. B., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.527 · Cited by 142
Ram, R., Wolach, O., Vidal, L., Gafter‐Gvili, A., Shpilberg, O., & Raanani, P. (2012) · American Journal of Hematology · doi:10.1002/ajh.23149 · Cited by 140
Second Malignant Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia
Schmiegelow, K., Levinsen, M., Attarbaschi, A., Baruchel, A., Devidas, M., Escherich, G., Gibson, B. E. S., Heydrich, C., Horibe, K., Ishida, Y., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.0500 · Cited by 139
Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia
Seki, M., Kimura, S., Isobe, T., Yoshida, K., Ueno, H., Nakajima-Takagi, Y., Wang, C., Lin, L., Kon, A., Suzuki, H., et al. (2017) · Nature Genetics · doi:10.1038/ng.3900 · Cited by 138
Self-citationEssig, S., Li, Q., Chen, Y., Hitzler, J. K., Leisenring, W. M., Greenberg, M., Sklar, C. A., Hudson, M. M., Armstrong, G. T., Krull, K. R., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70265-7 · Cited by 137
Moorman, A. V., Robinson, H. M., Schwab, C. J., Richards, S. M., Hancock, J. P., Mitchell, C., Goulden, N., Vora, A. J., & Harrison, C. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.9377 · Cited by 129
Attarbaschi, A., Mann, G., Panzer‐Grümayer, R., Röttgers, S., Steiner, M., König, M., Csinady, E., Dworzak, M. N., Seidel, M. G., Janousek, D., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.1117 · Cited by 111
Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions
Porter, C. C., Druley, T. E., Erez, A., Kuiper, R. P., Onel, K., Schiffman, J. D., Schneider, K. W., Scollon, S., Scott, H. S., Strong, L. C., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0428 · Cited by 111
Hayakawa, F., Sakura, T., Yujiri, T., Kondo, E., Fujimaki, K., Sasaki, O., Miyatake, J., Handa, H., Ueda, Y., Aoyama, Y., et al. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.72 · Cited by 109
Toyoda, Y., Manabe, A., Tsuchida, M., Hanada, R., Ikuta, K., Okimoto, Y., Ohara, A., Ohkawa, Y., Mori, T., Ishimoto, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1508 · Cited by 107
Self-citationAcute myeloid leukemia in children: Current status and future directions
Taga, T., Tomizawa, D., Takahashi, H., & Adachi, S. (2015) · Pediatrics International · doi:10.1111/ped.12865 · Cited by 101
Horibe, K., Saito, A. M., Takimoto, T., Tsuchida, M., Manabe, A., Shima, M., Ohara, A., & Mizutani, S. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1364-2 · Cited by 97
Self-citationOutcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels
Mullighan, C. G., Jeha, S., Pei, D., Payne-Turner, D., Coustan‐Smith, E., Roberts, K. G., Waanders, E., Choi, J. K., Ma, X., Raimondi, S. C., et al. (2015) · Blood · doi:10.1182/blood-2015-09-671131 · Cited by 85
Rubnitz, J. E., Wichlan, D., Devidas, M., Shuster, J. J., Linda, S. B., Kurtzberg, J., Bell, B. A., Hunger, S. P., Chauvenet, A. R., Pui, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3552 · Cited by 85
Imamura, T., Kiyokawa, N., Kato, M., Imai, C., Okamoto, Y., Yano, M., Ohki, K., Yamashita, Y. I., Kodama, Y., Saito, A., et al. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.28 · Cited by 68
Self-citationLong-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children
Kato, M., Ishimaru, S., Seki, M., Yoshida, K., Shiraishi, Y., Chiba, K., Kakiuchi, N., Sato, Y., Ueno, H., Tanaka, H., et al. (2016) · Leukemia · doi:10.1038/leu.2016.274 · Cited by 65
Self-citationChildhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progress
Goto, H. (2015) · Pediatrics International · doi:10.1111/ped.12837 · Cited by 42
Yamaji, K., Okamoto, T., Yokota, S., Watanabe, A., Horikoshi, Y., Asami, K., Kikuta, A., Hyakuna, N., Saikawa, Y., Ueyama, J., et al. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22620 · Cited by 39
Recent progress in the treatment of infant acute lymphoblastic leukemia
Tomizawa, D. (2015) · Pediatrics International · doi:10.1111/ped.12758 · Cited by 34
Manabe, A., Kawasaki, H., Shimada, H., Kato, I., Kodama, Y., Satō, A., Matsumoto, K., Kato, K., Yabe, H., Kudo, K., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.383 · Cited by 31
Self-citationCurrent evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia
Urayama, K. Y., Chokkalingam, A. P., Manabe, A., & Mizutani, S. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1220-9 · Cited by 25
Self-citationKato, M., Koh, K., Manabe, A., Saito, T., Hasegawa, D., Isoyama, K., Kinoshita, A., Maeda, M., Okimoto, Y., Kajiwara, M., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12632 · Cited by 12
Self-citation
Cited by
Voetterl, H., van Wingen, G., Michelini, G., Griffiths, K. R., Gordon, E., DeBeus, R., Korgaonkar, M. S., Loo, S. K., Palmer, D., Breteler, R., et al. (2023) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2022.02.007 · Cited by 35
Metadata
- Authors
- Kato, M., & Manabe, A.
- Venue
- Pediatrics International
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 60
- Issue
- 1
- Pages
- 4-12
- ISSN
- 1328-8067 (ISSN-L)
- 1442-200X
- OpenAlex
- W2769243422
- Cited by
- 261
- References
- 65
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.